BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel
Lobna R. Ezz Elarab, Manal El Mahdy, Khaled Abdel KarimVolume:
9
Language:
english
Pages:
8
DOI:
10.1007/s10330-010-0699-x
Date:
December, 2010
File:
PDF, 437 KB
english, 2010